Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The anti-angiogenic peptide anginex disrupts the cell membrane.

Pilch J, Franzin CM, Knowles LM, Ferrer FJ, Marassi FM, Ruoslahti E.

J Mol Biol. 2006 Mar 3;356(4):876-85. Epub 2005 Dec 20.

2.

Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide.

Dings RP, Arroyo MM, Lockwood NA, van Eijk LI, Haseman JR, Griffioen AW, Mayo KH.

Biochem J. 2003 Jul 1;373(Pt 1):281-8.

3.

Anginex-conjugated liposomes for targeting of angiogenic endothelial cells.

Brandwijk RJ, Mulder WJ, Nicolay K, Mayo KH, Thijssen VL, Griffioen AW.

Bioconjug Chem. 2007 May-Jun;18(3):785-90. Epub 2007 Mar 23.

PMID:
17378601
4.

Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein.

Brandwijk RJ, Nesmelova I, Dings RP, Mayo KH, Thijssen VL, Griffioen AW.

Biochem Biophys Res Commun. 2005 Aug 12;333(4):1261-8.

PMID:
15979575
5.

Anti-tumor activity of the novel angiogenesis inhibitor anginex.

Dings RP, van der Schaft DW, Hargittai B, Haseman J, Griffioen AW, Mayo KH.

Cancer Lett. 2003 May 8;194(1):55-66.

PMID:
12706859
6.

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW.

FASEB J. 2002 Dec;16(14):1991-3. Epub 2002 Oct 18.

7.

Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.

Wang JB, Wang MD, Li EX, Dong DF.

Peptides. 2012 Dec;38(2):457-62. doi: 10.1016/j.peptides.2012.09.007. Epub 2012 Sep 14. Review.

PMID:
22985857
8.

Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects.

Wieprecht T, Apostolov O, Beyermann M, Seelig J.

Biochemistry. 2000 Jan 18;39(2):442-52.

PMID:
10631006
9.

Anginex, a designed peptide that inhibits angiogenesis.

Griffioen AW, van der Schaft DW, Barendsz-Janson AF, Cox A, Struijker Boudier HA, Hillen HF, Mayo KH.

Biochem J. 2001 Mar 1;354(Pt 2):233-42.

10.

Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Upreti M, Jamshidi-Parsian A, Apana S, Berridge M, Fologea DA, Koonce NA, Henry RL, Griffin RJ.

J Mol Med (Berl). 2013 Apr;91(4):497-506. doi: 10.1007/s00109-012-0965-1. Epub 2012 Oct 23.

11.

Anti-angiogenesis and anti-tumor activity of recombinant anginex.

Brandwijk RJ, Dings RP, van der Linden E, Mayo KH, Thijssen VL, Griffioen AW.

Biochem Biophys Res Commun. 2006 Oct 27;349(3):1073-8. Epub 2006 Sep 5.

PMID:
16970922
12.

Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.

Ramamoorthy A, Thennarasu S, Tan A, Gottipati K, Sreekumar S, Heyl DL, An FY, Shelburne CE.

Biochemistry. 2006 May 23;45(20):6529-40.

13.

Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity.

Mayo KH, Dings RP, Flader C, Nesmelova I, Hargittai B, van der Schaft DW, van Eijk LI, Walek D, Haseman J, Hoye TR, Griffioen AW.

J Biol Chem. 2003 Nov 14;278(46):45746-52. Epub 2003 Aug 28.

14.

Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843.

Thennarasu S, Lee DK, Tan A, Prasad Kari U, Ramamoorthy A.

Biochim Biophys Acta. 2005 Jun 1;1711(1):49-58. Epub 2005 Mar 7.

15.

Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.

Thennarasu S, Tan A, Penumatchu R, Shelburne CE, Heyl DL, Ramamoorthy A.

Biophys J. 2010 Jan 20;98(2):248-57. doi: 10.1016/j.bpj.2009.09.060.

16.

CLT1 targets angiogenic endothelium through CLIC1 and fibronectin.

Knowles LM, Malik G, Hood BL, Conrads TP, Pilch J.

Angiogenesis. 2012 Mar;15(1):115-29. doi: 10.1007/s10456-011-9247-8. Epub 2011 Dec 28.

17.

Thermodynamics of melittin binding to lipid bilayers. Aggregation and pore formation.

Klocek G, Schulthess T, Shai Y, Seelig J.

Biochemistry. 2009 Mar 31;48(12):2586-96. doi: 10.1021/bi802127h.

PMID:
19173655
18.

Aggregation and porin-like channel activity of a beta sheet peptide.

Thundimadathil J, Roeske RW, Jiang HY, Guo L.

Biochemistry. 2005 Aug 2;44(30):10259-70.

PMID:
16042403
19.

Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.

Dathe M, Schümann M, Wieprecht T, Winkler A, Beyermann M, Krause E, Matsuzaki K, Murase O, Bienert M.

Biochemistry. 1996 Sep 24;35(38):12612-22.

PMID:
8823199
20.

Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.

Kobayashi S, Takeshima K, Park CB, Kim SC, Matsuzaki K.

Biochemistry. 2000 Jul 25;39(29):8648-54.

PMID:
10913273
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk